G49108TO
| Organisms | Evidence |
|---|---|
| Streptococcus pneumoniae | |
| Mus musculus (house mouse) | |
| Saccharomyces cerevisiae (brewer's yeast) | |
| Sus scrofa (pig) | |
| Rattus norvegicus (Norway rat) |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT1 | UDP-Gal |
|
R |
|
R | |
| B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
| B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
| B3GALT5 | UDP-Gal |
|
R |
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-thio-p-Nitrophenyl |
|
[beta]-1-thio-p-Nitrophenyl | |
| B4GALT3 | UDP-Gal |
|
4-Me-lumbelyl-[beta] |
|
4-Me-lumbelyl-[beta] | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl | |
| B4GALT1 | UDP-Gal |
|
|
| UniProt ID | Protein Name | Reference | Source |
|---|---|---|---|
| Q9NVQ4 | Fas apoptotic inhibitory molecule 1 | ||
| Q9NVR2 | Integrator complex subunit 10 | ||
| Q9NVX0 | HAUS augmin-like complex subunit 2 | ||
| Q9NW08 | DNA-directed RNA polymerase III subunit RPC2 | ||
| Q9NW64 | Pre-mRNA-splicing factor RBM22 | ||
| Q9NW75 | G patch domain-containing protein 2 | ||
| Q9NW82 | WD repeat-containing protein 70 | ||
| Q9NWA0 | Mediator of RNA polymerase II transcription subunit 9 | ||
| Q9NWB6 | Arginine and glutamate-rich protein 1 | ||
| Q9NWH9 | SAFB-like transcription modulator |
| Pathway Name | Organism |
|---|---|
| E.coli O4-H5 | Escherichia coli |
| E.coli O4-K52 | Escherichia coli |
| E.coli O40 | Escherichia coli |
| E.coli O41 | Escherichia coli |
| E.coli O42 | Escherichia coli |
| E.coli O45rel | Escherichia coli |
| E.coli O48 | Escherichia coli |
| E.coli O53 | Escherichia coli |
| E.coli O55 | Escherichia coli |
| E.coli O56 | Escherichia coli |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 39531497 | Ultradeep O-GlcNAc proteomics reveals widespread O-GlcNAcylation on tyrosine residues of proteins | Hou C | 2024 Nov 12 |
|
| 39532904 | Structures of complete extracellular assemblies of type I and type II Oncostatin M receptor complexes | Zhou Y | 2024 Nov 12 |
|
| 39511418 | Mechanistic study of SCOOPs recognition by MIK2–BAK1 complex reveals the role of N-glycans in plant ligand–receptor–coreceptor complex formation | Wu H | 2024 Nov 07 |
|
| 39509538 | Opportunities for Therapeutic Modulation of O-GlcNAc | Cheng SS | 2024 Nov 07 |
|
| 39594580 | Modifying the Glycocalyx of Melanoma Cells via Metabolic Glycoengineering Using N-Acetyl-d-glucosamine Analogues | Harris D | 2024 Nov 06 |
|
| 39503754 | TMEM106B amyloid filaments in the Biondi bodies of ependymal cells | Ghetti B | 2024 Nov 06 |
|
| 39304040 | Structural and biochemical insights into the molecular mechanism of N-acetylglucosamine/N-Acetylmuramic acid kinase MurK from Clostridium acetobutylicum | He X | 2024 Nov |
|
| 39395796 | Site-specific O-GlcNAcylation of progesterone receptor (PR) supports PR attenuation of interferon stimulated genes (ISGs) and tumor growth in breast cancer | Saunders HI | 2024 Nov |
|
| 39414231 | From Fringe to the Mainstream: How ETD MS Brought O-GlcNAc to the Masses | Udeshi ND | 2024 Nov |
|
| 38631666 | Crystal Structure of Bimekizumab Fab Fragment in Complex with IL-17F Provides Molecular Basis for Dual IL-17A and IL-17F Inhibition | Adams R | 2024 Nov |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025